Elekta Esprit
Leksell Gamma Knife

Patients at the center

Precision that spares healthy brain tissue

This proven technology spares healthy tissue due to its unique design using 192 simultaneous radiation beams with outstanding precision.

Find out how it works:

Treat a broad range of intracranial indications

Our users treat >60 different indications* with Leksell Gamma Knife, every treatment is personalized to fit the patients need and condition.

Explore a selection of case studies to find out more:

*Based on LGK Society Treatment Statistics 2020

Brain metastases

Gamma Knife radiosurgery combined with immunotherapy resulted in complete remission of the patient’s metastases, both intracranial and systemic.

Read case study

Trigeminal Neuralgia

Pain alleviation using conservative treatment was not sufficient for this multiple sclerosis patient. Gamma Knife radiosurgery provided an effective, non-invasive alternative to achieve excellent results, reducing facial pain significantly.

Read case study

Vestibular Schwannoma

Gamma Knife radiosurgery combined with immunotherapy resulted in complete remission of the patient’s metastases, both intracranial and systemic.

Protect your patient's quality of life with very low dose to the brain and body

Brain

By delivering the radiation dose with 192 small beams to a focused isocenter, Gamma Knife radiosurgery has 2-21x lower dose to healthy brain tissue compared to competing technologies.

Body

The unique design of Leksell Gamma Knife means that there is less radiation outside the target and no primary beams are directed from the top of the head through the body, resulting in 2-235x lower dose to body compared to competing technologies.

Well documented treatment for intracranial stereotactic radiosurgery

Read about the supporting research on Gamma Knife radiosurgery for a selection of the indications:

Meningioma

Over 95% tumor control for WHO Grade I Meningioma1 and overall significant improvement in Quality of Life (QoL),2

View bibliography

Vestibular Schwannoma

75% chance of preserving hearing and 80% tumour control rate as well as improved QoL2,3

View bibliography

Brain Metastases

Stable or improved QoL and preserved cognitive function4,5,6

View bibliography

Find your nearest Leksell Gamma Knife treatment center

Receive material for patients

Access useful tools for educating patients on treatment with Gamma Knife radiosurgery and be automatically put on the waitlist to receive a case study on Vestibular Schwannoma

Request patient information

References

1. Hafez et al. Acta Neurochir (Wien). 2015;157(9):1559–64. 8. doi: 10.1007/s00701-015-2509-2

2. Shyamal et al. J La State Med Soc.2015;167(2):54–65.

3. Janz et al. Otol Neurotol. 2019;40(8):1047–53. 22. doi: 10.1097/MAO.0000000000002316 .

4. Verhaak et al. Neurosurgery. 2021 Apr; 88(5):E396-E405.

5. Schimmel et al. Clin Oncol (R Coll Radiol). 2021 May; 33(5):314-321.

6. Bragstad et al. J Neurosurg. 2018 Jul; 129(1):71-83

7. Paddick et al. 2021, 2. Data courtesy of Ian Paddick 2023, 3. Eaton et al. Pract Radiat Oncol 2018, 4.Eaton et al. Pract Radiat Oncol 2018, 5. Cao et al. J Neurosurg 2019, 6. Schelin et al. J Rasiosurg SBRT 2021

Looking for our patient guide to Leksell Gamma Knife radiosurgery?

Read about the treatment journey and patient stories, find your nearest Gamma Knife center or download our treatment journey flyer in your language.

Take me to the patient guide
Close